Completion of Novo Nordisk s Acquisition of a Controlling Stake in BIOCORP pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
04.08.2023 - Regulatory News: Following the announcement of the planned acquisition of BIOCORP Production SA (FR0012788065 - ALCOR) (“BIOCORP”) by NOVO NORDISK (DK0060534915 - Novo-B), a leading global healthcare company headquartered in Denmark and developing .
Novo Nordisk A/S and BIOCORP Production SA announced on June 5 that Novo Nordisk has entered into exclusive negotiations for a controlling stake in BIOCORP, which would be followed by a mandatory simplified tender offer on all remaining outstanding shares in BIOCORP1 at a price of 35.00 Euros per share in cash, representing a total equity value of approximately 154 million Euros.
Novo Nordisk has entered into exclusive negotiations with BIO JAG, BIOCORP's main shareholder, for the purchase of its entire stake in BIOCORP, representing 45.3% of its share capital and 62.19%